Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Spanogiannopoulos

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Nature Reviews. Gastroenterology & Hepatology|May 13, 2018
Broad collateral damage of drugs against the gut microbiomePeter Spanogiannopoulos, Peter J Turnbaugh
Cellular and Molecular Life Sciences : CMLS|October 29, 2009
The tetracycline resistomeMaulik Thaker, Peter Spanogiannopoulos, Gerard D Wright
Accounts of Chemical Research|April 20, 2021
The Enzymes of the Rifamycin Antibiotic ResistomeMatthew D Surette, Peter Spanogiannopoulos, Gerard D Wright
Proceedings of the National Academy of Sciences of the United States of America|April 30, 2014
A rifamycin inactivating phosphotransferase family shared by environmental and pathogenic bacteriaPeter Spanogiannopoulos, Nicholas Waglechner, Kalinka Koteva, et al.
Nature Reviews. Microbiology|March 15, 2016
The microbial pharmacists within us: a metagenomic view of xenobiotic metabolismPeter Spanogiannopoulos, Elizabeth N Bess, Rachel N Carmody, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2012
Characterization of a rifampin-inactivating glycosyltransferase from a screen of environmental actinomycetesPeter Spanogiannopoulos, Maulik Thaker, Kalinka Koteva, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 17, 2018
How to Determine the Role of the Microbiome in Drug DispositionJordan E Bisanz, Peter Spanogiannopoulos, Lindsey M Pieper, et al.
Nature Biotechnology|September 24, 2013
Identifying producers of antibacterial compounds by screening for antibiotic resistanceMaulik N Thaker, Wenliang Wang, Peter Spanogiannopoulos, et al.
Mbio|August 29, 2023
The global anaerobic metabolism regulator <i>fnr</i> is necessary for the degradation of food dyes and drugs by <i>Escherichia coli</i>Lindsey M Pieper, Peter Spanogiannopoulos, Regan F Volk, et al.
The Biochemical Journal|June 14, 2013
Structure-guided optimization of protein kinase inhibitors reverses aminoglycoside antibiotic resistancePeter J Stogios, Peter Spanogiannopoulos, Elena Evdokimova, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Nature Reviews. Gastroenterology & Hepatology|May 13, 2018
Broad collateral damage of drugs against the gut microbiomePeter Spanogiannopoulos, Peter J Turnbaugh
Cellular and Molecular Life Sciences : CMLS|October 29, 2009
The tetracycline resistomeMaulik Thaker, Peter Spanogiannopoulos, Gerard D Wright
Accounts of Chemical Research|April 20, 2021
The Enzymes of the Rifamycin Antibiotic ResistomeMatthew D Surette, Peter Spanogiannopoulos, Gerard D Wright
Proceedings of the National Academy of Sciences of the United States of America|April 30, 2014
A rifamycin inactivating phosphotransferase family shared by environmental and pathogenic bacteriaPeter Spanogiannopoulos, Nicholas Waglechner, Kalinka Koteva, et al.
Nature Reviews. Microbiology|March 15, 2016
The microbial pharmacists within us: a metagenomic view of xenobiotic metabolismPeter Spanogiannopoulos, Elizabeth N Bess, Rachel N Carmody, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2012
Characterization of a rifampin-inactivating glycosyltransferase from a screen of environmental actinomycetesPeter Spanogiannopoulos, Maulik Thaker, Kalinka Koteva, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 17, 2018
How to Determine the Role of the Microbiome in Drug DispositionJordan E Bisanz, Peter Spanogiannopoulos, Lindsey M Pieper, et al.
Nature Biotechnology|September 24, 2013
Identifying producers of antibacterial compounds by screening for antibiotic resistanceMaulik N Thaker, Wenliang Wang, Peter Spanogiannopoulos, et al.
Mbio|August 29, 2023
The global anaerobic metabolism regulator <i>fnr</i> is necessary for the degradation of food dyes and drugs by <i>Escherichia coli</i>Lindsey M Pieper, Peter Spanogiannopoulos, Regan F Volk, et al.
The Biochemical Journal|June 14, 2013
Structure-guided optimization of protein kinase inhibitors reverses aminoglycoside antibiotic resistancePeter J Stogios, Peter Spanogiannopoulos, Elena Evdokimova, et al.
Pageof 2